Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of Syntropin (a human growth
hormone) and to determine the serum concentration of IGF-1 after Syntropin injection.